Research programme: autologous cultured chondrocytes - Advanced Tissue Sciences

Drug Profile

Research programme: autologous cultured chondrocytes - Advanced Tissue Sciences

Alternative Names: Cartilage replacement - Advanced Tissue Sciences; Liquid cartilage replacement - Advanced Tissue Sciences; NeoCyte™

Latest Information Update: 25 Aug 2006

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Advanced Tissue Sciences [CEASED]
  • Class Cell therapies
  • Mechanism of Action Cartilage replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Knee injuries

Most Recent Events

  • 25 Aug 2006 Discontinued - Preclinical for Knee injuries in USA (Injection)
  • 21 Nov 2002 Advanced Tissue Sciences has decided to liquidate its business
  • 18 Oct 2002 Advanced Tissue Sciences has filed under Chapter 11 of the US Bankruptcy Code
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top